Table 1.
Demographic, behavioral, and clinical characteristics in the total sample of people with HIV and by sex.
| Sex | ||||
|---|---|---|---|---|
| Total | Men | Women | ||
| (N = 1,666) | (n = 1,465) | (n = 201) | ||
| n (%) | n (%) | n (%) | P-value | |
| Age, M (SD) | 41.7 (9.8) | 41.9 (9.8) | 40.7 (9.6) | 0.09 |
| Years of education, M (SD) | 13.3 (2.7) | 13.5 (2.7) | 12.0 (2.5) | <0.001 |
| WRAT-4, M (SD) | 99.1 (13.5) | 99.8 (13.3) | 93.5 (13.2) | <0.001 |
| Race | <0.001 | |||
| White | 971 (58) | 890 (61) | 81 (40) | |
| Black | 314 (19) | 259 (18) | 55 (28) | |
| Hispanic | 299 (18) | 246 (17) | 53 (26) | |
| Other | 82 (5) | 70 (4) | 12 (6) | |
| IADL dependence | 2.5 (2.9) | 2.4 (2.8) | 2.9 (3.1) | 0.03 |
| BDI-II | 13.5 (10.4) | 13.5 (10.4) | 13.5 (9.9) | 0.99 |
| DSM-IV (CIDI) diagnoses | ||||
| MDD | ||||
| Current | 224 (19) | 203 (19) | 21 (18) | 0.94 |
| Lifetime | 572 (48) | 510 (48) | 572 (48) | 0.24 |
| Alcohol (current or lifetime*) | 72 (6) | 66 (6) | 6 (5) | 0.84 |
| Cannabis (current or lifetime*) | 63 (5) | 60 (6) | 3 (3) | 0.25 |
| Substance use (current or lifetime*) | 691 (73) | 627 (73) | 64 (71) | 0.74 |
| Anticholinergic medications | 422 (25) | 367 (25) | 55 (27) | 0.53 |
| Hypertension | 334 (21) | 298 (21) | 36 (18) | 37 |
| Hyperlipidemia | 219 (14) | 193 (14) | 26 (13) | 0.9 |
| Diabetes | 82 (5) | 70 (5) | 12 (6) | 0.64 |
| HCV | 317 (20) | 259 (18) | 58 (29) | <0.001 |
| Log plasma viral load, M (SD) | 3.1 (1.3) | 3.1 (1.3) | 3.1 (1.2) | 0.83 |
| CD4 count, M (SD) | ||||
| Current | 429.0 (296.9) | 426.9 (295.8) | 443.7 (305.3) | 0.46 |
| Nadir | 229.9 (219.9) | 250.4 (231.8) | 232.4 (221.4) | 0.21 |
| Duration of HIV disease, M (SD) | 9.1 (7.8) | 9.3 (8.0) | 7.0 (5.6) | 0.005 |
| AIDS diagnosis | 969 (58) | 854 (59) | 115 (57) | 0.07 |
| On ART | 966 (60) | 857 (60) | 109 (56) | 0.3 |
M, mean; SD, standard deviation; ART, antiretroviral therapy; WRAT-4, Wide Range Achievement Test; IADL, Instrumental Activities of Daily Living; BDI, Beck depression inventory; CIDI, Composite International Diagnostic Interview; HCV, Hepatitis C.
*
Current or Lifetime Use disorder (abuse or dependence).